- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Stable Growth Stocks
Global Pharmaceuticals & Biotech Stable Growth Stocks
Results
81
81 companies
Emcure Pharmaceuticals
Market Cap: ₹285.1b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,504.50
7D
3.5%
1Y
10.3%
Shionogi
Market Cap: JP¥2.3t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
4507
JP¥2,648.50
7D
-2.1%
1Y
20.3%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹270.4b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,728.00
7D
0.7%
1Y
-10.2%
WuXi Biologics (Cayman)
Market Cap: HK$124.6b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$30.62
7D
-0.6%
1Y
169.5%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥31.8b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥48.15
7D
12.6%
1Y
71.0%
Dottikon ES Holding
Market Cap: CHF 4.0b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries worldwide.
DESN
CHF 292.50
7D
-2.3%
1Y
14.5%
ALK-Abelló
Market Cap: DKK 41.6b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 187.90
7D
2.6%
1Y
17.1%
Virbac
Market Cap: €2.9b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
VIRP
€341.50
7D
3.6%
1Y
-2.1%
Xiamen Amoytop Biotech
Market Cap: CN¥34.9b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥85.86
7D
-1.4%
1Y
81.0%
Swedish Orphan Biovitrum
Market Cap: SEK 97.9b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 284.20
7D
3.2%
1Y
-4.9%
Siegfried Holding
Market Cap: CHF 3.9b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 90.10
7D
2.5%
1Y
-10.3%
Novo Nordisk
Market Cap: DKK 1.5t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 345.60
7D
6.0%
1Y
-61.6%
Pharmaron Beijing
Market Cap: CN¥49.8b
Provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally.
300759
CN¥29.89
7D
-3.1%
1Y
51.9%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥40.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥90.32
7D
0.8%
1Y
88.1%
WuXi XDC Cayman
Market Cap: HK$69.4b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.65
7D
-6.9%
1Y
213.0%
Torrent Pharmaceuticals
Market Cap: ₹1.2t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,662.95
7D
1.2%
1Y
9.3%
Zhejiang Jingxin Pharmaceutical
Market Cap: CN¥15.7b
Zhejiang Jingxin Pharmaceutical Co., Ltd.
002020
CN¥18.97
7D
-5.1%
1Y
66.4%
Jilin Aodong Pharmaceutical Group
Market Cap: CN¥23.5b
Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
CN¥20.08
7D
2.5%
1Y
54.5%
Pfizer
Market Cap: ₹258.7b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹5,655.50
7D
10.7%
1Y
-5.4%
Haleon
Market Cap: UK£33.1b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.69
7D
2.8%
1Y
-0.7%
Alkem Laboratories
Market Cap: ₹644.8b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,393.00
7D
0.08%
1Y
-6.9%
Avantor
Market Cap: US$8.8b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$12.88
7D
-1.5%
1Y
-49.4%
Corcept Therapeutics
Market Cap: US$7.4b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$70.40
7D
-2.2%
1Y
105.4%
Halozyme Therapeutics
Market Cap: US$8.2b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$71.13
7D
9.2%
1Y
14.4%
Livzon Pharmaceutical Group
Market Cap: CN¥34.1b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥40.49
7D
0.5%
1Y
12.1%
Bora Pharmaceuticals
Market Cap: NT$92.7b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$747.00
7D
-2.4%
1Y
15.2%
PharmaResearch
Market Cap: ₩6.8t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩653,000.00
7D
-1.8%
1Y
258.8%
Camurus
Market Cap: SEK 40.2b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 676.00
7D
4.9%
1Y
-3.4%
Merck KGaA
Market Cap: €48.5b
Operates as a science and technology company in Germany.
MRK
€111.65
7D
0.5%
1Y
-34.4%
PharmaEssentia
Market Cap: NT$166.1b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$498.50
7D
0.1%
1Y
-28.3%
Shanghai Henlius Biotech
Market Cap: HK$42.9b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$79.00
7D
2.7%
1Y
242.7%
CSL
Market Cap: AU$106.9b
Engages in the research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$220.74
7D
-18.1%
1Y
-28.4%
Shanghai RAAS Blood Products
Market Cap: CN¥45.9b
Engages in the manufacture and sale of blood products in China.
002252
CN¥6.95
7D
0.1%
1Y
-6.8%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥14.8b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥46.88
7D
1.9%
1Y
5.7%
Zealand Pharma
Market Cap: DKK 28.8b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 408.50
7D
19.8%
1Y
-53.3%
Eli Lilly
Market Cap: US$631.3b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$705.44
7D
6.8%
1Y
-25.9%